The Dipeptidyl Peptidase Family, Prolyl Oligopeptidase, and Prolyl Carboxypeptidase in the Immune System and Inflammatory Disease, Including Atherosclerosis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Dipeptidyl Peptidase Family, Prolyl Oligopeptidase, and Prolyl Carboxypeptidase in the Immune System and Inflammatory Disease, Including Atherosclerosis
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 6, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2015-08-10
DOI
10.3389/fimmu.2015.00387
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Regulation of dipeptidyl peptidase 8 and 9 expression in activated lymphocytes and injured liver
- (2017) Sumaiya Chowdhury et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The effects of a TGR5 agonist and a dipeptidyl peptidase IV inhibitor on dextran sulfate sodium-induced colitis in mice
- (2015) Taisuke Sakanaka et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy
- (2015) Rosa Barreira da Silva et al. NATURE IMMUNOLOGY
- Dipeptidyl-Peptidase-4 Inhibitor, Alogliptin, Attenuates Arterial Inflammation and Neointimal Formation After Injury in Low-Density Lipoprotein (LDL) Receptor-Deficient Mice
- (2015) K. Akita et al. Journal of the American Heart Association
- Increased plasma DPP4 activities predict new-onset atherosclerosis in association with its proinflammatory effects in Chinese over a four year period: A prospective study
- (2014) T.P. Zheng et al. ATHEROSCLEROSIS
- DPP-4 Inhibitors Repress NLRP3 Inflammasome and Interleukin-1beta via GLP-1 Receptor in Macrophages Through Protein Kinase C Pathway
- (2014) Yao Dai et al. CARDIOVASCULAR DRUGS AND THERAPY
- The amino terminus extension in the long dipeptidyl peptidase 9 isoform contains a nuclear localization signal targeting the active peptidase to the nucleus
- (2014) Daniela Justa-Schuch et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial
- (2014) Benjamin M. Scirica et al. CIRCULATION
- Human treg cells are characterized by low/negative CD6 expression
- (2014) Carlos A. Garcia Santana et al. CYTOMETRY PART A
- Alogliptin: a new dipeptidyl peptidase-4 inhibitor with potential anti-atherogenic properties
- (2014) Eiji Kutoh et al. ENDOCRINE RESEARCH
- Inhibition of CD26/Dipeptidyl Peptidase IV Enhances CCL11/Eotaxin-Mediated Recruitment of Eosinophils In Vivo
- (2014) U. Forssmann et al. JOURNAL OF IMMUNOLOGY
- A Novel Proteolytic Cascade Generates an Extracellular Matrix-Derived Chemoattractant in Chronic Neutrophilic Inflammation
- (2014) A. Gaggar et al. JOURNAL OF IMMUNOLOGY
- Prolyl Carboxypeptidase Activity Decline Correlates with Severity and Short-Term Outcome in Acute Ischemic Stroke
- (2014) Kaat Kehoe et al. NEUROCHEMICAL RESEARCH
- Soluble DPP4 originates in part from bone marrow cells and not from the kidney
- (2014) Zhendi Wang et al. PEPTIDES
- Validation of a specific prolylcarboxypeptidase activity assay and its suitability for plasma and serum measurements
- (2013) Kaat Kehoe et al. ANALYTICAL BIOCHEMISTRY
- Decreased carotid atherosclerotic process by control of daily acute glucose fluctuations in diabetic patients treated by DPP-IV inhibitors
- (2013) M. Barbieri et al. ATHEROSCLEROSIS
- DPP-4 inhibitors and atherosclerosis: The promise
- (2013) Ishwarlal Jialal et al. ATHEROSCLEROSIS
- Dipeptidyl peptidases in atherosclerosis: expression and role in macrophage differentiation, activation and apoptosis
- (2013) Veerle Matheeussen et al. BASIC RESEARCH IN CARDIOLOGY
- Alteration of prolyl oligopeptidase and activated α-2-macroglobulin in multiple sclerosis subtypes and in the clinically isolated syndrome
- (2013) Jofre Tenorio-Laranga et al. BIOCHEMICAL PHARMACOLOGY
- Contribution of Dipeptidyl Peptidase IV to the Severity of Dextran Sulfate Sodium-Induced Colitis in the Early Phase
- (2013) Hitoshi IWAYA et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- SDF-1 promotes ox-LDL induced vascular smooth muscle cell proliferation
- (2013) Ling-Xing Li et al. CELL BIOLOGY INTERNATIONAL
- Dipeptidyl Peptidase-4 Inhibitor, Sitagliptin, Improves Endothelial Dysfunction in Association With Its Anti-Inflammatory Effects in Patients With Coronary Artery Disease and Uncontrolled Diabetes
- (2013) Junichi Matsubara et al. CIRCULATION JOURNAL
- Polyarthropathy in type 2 diabetes patients treated with DPP4 inhibitors
- (2013) Tatsuhiko Saito et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Anagliptin, a DPP-4 Inhibitor, Suppresses Proliferation of Vascular Smooth Muscles and Monocyte Inflammatory Reaction and Attenuates Atherosclerosis in Male apo E-Deficient Mice
- (2013) Nasib Ervinna et al. ENDOCRINOLOGY
- Fibroblast activation protein expression by stromal cells and tumor-associated macrophages in human breast cancer
- (2013) Julia Tchou et al. HUMAN PATHOLOGY
- Prolyl oligopeptidase is a glyceraldehyde-3-phosphate dehydrogenase-binding protein that regulates genotoxic stress-induced cell death
- (2013) Takashi Matsuda et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Evidence for the antagonistic form of CXC-motif chemokine CXCL10 in serous epithelial ovarian tumours
- (2013) Adam Rainczuk et al. INTERNATIONAL JOURNAL OF CANCER
- Antidiabetic gliptins in combination with G-CSF enhances myocardial function and survival after acute myocardial infarction
- (2013) Hans D. Theiss et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The SUMO1-E67 Interacting Loop Peptide Is an Allosteric Inhibitor of the Dipeptidyl Peptidases 8 and 9
- (2013) Esther Pilla et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identifying Natural Substrates for Dipeptidyl Peptidases 8 and 9 Using Terminal Amine Isotopic Labeling of Substrates (TAILS) Revealsin VivoRoles in Cellular Homeostasis and Energy Metabolism
- (2013) Claire H. Wilson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dipeptidyl Peptidase IV Is a Human and Murine Neutrophil Chemorepellent
- (2013) S. E. Herlihy et al. JOURNAL OF IMMUNOLOGY
- Inhibition of intracellular dipeptidyl peptidases 8 and 9 enhances parthenolide’s anti-leukemic activity
- (2013) P A Spagnuolo et al. LEUKEMIA
- Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
- (2013) V. Stalin Raj et al. NATURE
- Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis
- (2013) Tasha E Fingerlin et al. NATURE GENETICS
- Prolyl oligopeptidase colocalizes with α-synuclein, β-amyloid, tau protein and astroglia in the post-mortem brain samples with Parkinson’s and Alzheimer’s diseases
- (2013) M.J. Hannula et al. NEUROSCIENCE
- Preventive Effect of Dipeptidyl Peptidase-4 Inhibitor on Atherosclerosis Is Mainly Attributable to Incretin's Actions in Nondiabetic and Diabetic Apolipoprotein E-Null Mice
- (2013) Michishige Terasaki et al. PLoS One
- Targeted Inactivation of Dipeptidyl Peptidase 9 Enzymatic Activity Causes Mouse Neonate Lethality
- (2013) Margaret G. Gall et al. PLoS One
- Levels of dipeptidyl peptidase IV/CD26 substrates neuropeptide Y and vasoactive intestinal peptide in rheumatoid arthritis patients
- (2013) Suncica Buljevic et al. RHEUMATOLOGY INTERNATIONAL
- Dipeptidyl peptidase-4 inhibitor anagliptin facilitates restoration of dextran sulfate sodium-induced colitis
- (2013) Shunya Mimura et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Selective Inhibitors of Fibroblast Activation Protein (FAP) with a (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine Scaffold
- (2013) Koen Jansen et al. ACS Medicinal Chemistry Letters
- Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs
- (2013) Fiona M. Keane et al. FEBS Open Bio
- Upregulation of SDF-1 is Associated with Atherosclerosis Lesions Induced by LDL Concentration Polarization
- (2012) Dangheng Wei et al. ANNALS OF BIOMEDICAL ENGINEERING
- Acylated Gly-(2-cyano)pyrrolidines as inhibitors of fibroblast activation protein (FAP) and the issue of FAP/prolyl oligopeptidase (PREP)-selectivity
- (2012) Oxana Ryabtsova et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A prolyl oligopeptidase inhibitor, KYP-2047, reduces α-synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease
- (2012) TT Myöhänen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Prolyl Endopeptidase-Deficient Mice Have Reduced Synaptic Spine Density in the CA1 Region of the Hippocampus, Impaired LTP, and Spatial Learning and Memory
- (2012) G. D'Agostino et al. CEREBRAL CORTEX
- Plasma Prolylcarboxypeptidase (Angiotensinase C) Is Increased in Obesity and Diabetes Mellitus and Related to Cardiovascular Dysfunction
- (2012) S. Xu et al. CLINICAL CHEMISTRY
- Influence of a Novel Inhibitor (UM8190) of Prolylcarboxypeptidase (PRCP) on Appetite and Thrombosis
- (2012) F. M. Rabey et al. CURRENT MEDICINAL CHEMISTRY
- CD26: A negative selection marker for human Treg cells
- (2012) Francisco J. Salgado et al. CYTOMETRY PART A
- A Potential Role for Dendritic Cell/Macrophage-Expressing DPP4 in Obesity-Induced Visceral Inflammation
- (2012) Jixin Zhong et al. DIABETES
- Sitagliptin reduces plaque macrophage content and stabilises arteriosclerotic lesions in Apoe −/− mice
- (2012) F. Vittone et al. DIABETOLOGIA
- CD26-mediated co-stimulation in human CD8+T cells provokes effector function via pro-inflammatory cytokine production
- (2012) Ryo Hatano et al. IMMUNOLOGY
- Sitagliptin (DPP-4 Inhibitor)-induced Rheumatoid Arthritis in Type 2 Diabetes Mellitus: A Case Report
- (2012) Kazuki Yokota et al. INTERNAL MEDICINE
- A Novel SUMO1-specific Interacting Motif in Dipeptidyl Peptidase 9 (DPP9) That Is Important for Enzymatic Regulation
- (2012) Esther Pilla et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Human Th17 Cells Express High Levels of Enzymatically Active Dipeptidylpeptidase IV (CD26)
- (2012) B. Bengsch et al. JOURNAL OF IMMUNOLOGY
- Dipeptidyl peptidase IV, aminopeptidase N and DPIV/APN-like proteases in cerebral ischemia
- (2012) Peter Röhnert et al. Journal of Neuroinflammation
- A Dipeptidyl Peptidase-4 Inhibitor, Des-Fluoro-Sitagliptin, Improves Endothelial Function and Reduces Atherosclerotic Lesion Formation in Apolipoprotein E–Deficient Mice
- (2012) Junichi Matsubara et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of PKF275-055, a dipeptidyl peptidase–4 inhibitor, on the development of atherosclerotic lesions in apolipoprotein E–null mice
- (2012) Michishige Terasaki et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Global identification of peptidase specificity by multiplex substrate profiling
- (2012) Anthony J O'Donoghue et al. NATURE METHODS
- Dipeptidyl peptidase 4 as a therapeutic target in ischemia/reperfusion injury
- (2012) Veerle Matheeussen et al. PHARMACOLOGY & THERAPEUTICS
- Structures of Human DPP7 Reveal the Molecular Basis of Specific Inhibition and the Architectural Diversity of Proline-Specific Peptidases
- (2012) Gustavo Arruda Bezerra et al. PLoS One
- Dipeptidyl peptidase-4 expression is reduced in Crohn's disease
- (2012) G.W. Moran et al. REGULATORY PEPTIDES
- Psoriasiform eruption triggered by a dipeptidyl peptidase IV inhibitor
- (2011) Albert Mas-Vidal et al. AUSTRALASIAN JOURNAL OF DERMATOLOGY
- Dipeptidyl Peptidase 2 is an essential survival factor in the regulation of cell quiescence
- (2011) Deanna A. Mele et al. CELL CYCLE
- Long-Term Dipeptidyl-Peptidase 4 Inhibition Reduces Atherosclerosis and Inflammation via Effects on Monocyte Recruitment and Chemotaxis
- (2011) Zubair Shah et al. CIRCULATION
- Interaction of Prolyl Oligopeptidase with α-Synuclein
- (2011) Anne-Marie Lambeir CNS & Neurological Disorders-Drug Targets
- Prolyl Oligopeptidase: A Rising Star on the Stage of Neuroinflammation Research
- (2011) Anne Penttinen et al. CNS & Neurological Disorders-Drug Targets
- Sitagliptin, a Dipeptidyl Peptidase-IV Inhibitor, Improves Psoriasis
- (2011) Tatsuya Nishioka et al. DERMATOLOGY
- High mobility group box 1 is a novel substrate of dipeptidyl peptidase-IV
- (2011) C. Marchetti et al. DIABETOLOGIA
- Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata
- (2011) Chad E. Brokopp et al. EUROPEAN HEART JOURNAL
- Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction
- (2011) Jacob Lønborg et al. EUROPEAN HEART JOURNAL
- Neuropeptide Y, B-type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein-α
- (2011) Fiona M. Keane et al. FEBS Journal
- CD26/dipeptidyl-peptidase IV and adenosine deaminase serum levels in psoriatic patients treated with cyclosporine, etanercept, and psoralen plus ultraviolet A phototherapy
- (2011) Fatma Elif Yıldırım et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Dipeptidyl Peptidases as Survival Factors in Ewing Sarcoma Family of Tumors
- (2011) Congyi Lu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- DPP-4 (CD26) Inhibitor Alogliptin Inhibits Atherosclerosis in Diabetic Apolipoprotein E–Deficient Mice
- (2011) Nga N Ta et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Biochemical and histological changes in the small intestine of mice with dextran sulfate sodium colitis
- (2011) Roger Yazbeck et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Structure–Activity Relationship Studies on Isoindoline Inhibitors of Dipeptidyl Peptidases 8 and 9 (DPP8, DPP9): Is DPP8-Selectivity an Attainable Goal?
- (2011) Sebastiaan Van Goethem et al. JOURNAL OF MEDICINAL CHEMISTRY
- Serum soluble CD26 levels: diagnostic efficiency for atopic dermatitis, cutaneous T-cell lymphoma and psoriasis in combination with serum thymus and activation-regulated chemokine levels
- (2011) T. Miyagaki et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- A Novel Role of Dipeptidyl Peptidase 9 in Epidermal Growth Factor Signaling
- (2011) T.-W. Yao et al. MOLECULAR CANCER RESEARCH
- The effect of prolyl oligopeptidase inhibition on extracellular acetylcholine and dopamine levels in the rat striatum
- (2011) Aaro J. Jalkanen et al. NEUROCHEMISTRY INTERNATIONAL
- The DPP-IV inhibitor ER-319711 has a proliferative effect on the colonic epithelium and a minimal effect in the amelioration of colitis
- (2011) Shigeki Bamba ONCOLOGY REPORTS
- Neutral aminopeptidase and dipeptidyl peptidase IV in the development of collagen II-induced arthritis
- (2011) Simone Cristina Yamasaki et al. REGULATORY PEPTIDES
- Serum levels of soluble CD26 and CD30 and their clinical significance in patients with rheumatoid arthritis
- (2011) Hasan Ulusoy et al. RHEUMATOLOGY INTERNATIONAL
- Cardiovascular effects of DPP-4 inhibition: Beyond GLP-1
- (2011) Gian Paolo Fadini et al. VASCULAR PHARMACOLOGY
- DPP-4 (CD26) inhibitor alogliptin inhibits TLR4-mediated ERK activation and ERK-dependent MMP-1 expression by U937 histiocytes
- (2010) Nga N. Ta et al. ATHEROSCLEROSIS
- GAP43 shows partial co-localisation but no strong physical interaction with prolyl oligopeptidase
- (2010) Zoltán Szeltner et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Prolyl oligopeptidase induces angiogenesis bothin vitroandin vivoin a novel regulatory manner
- (2010) TT Myöhänen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Expression and functional role of 1F7 (CD26) antigen on peripheral blood and synovial fluid T cells in rheumatoid arthritis patients
- (2010) C. MUSCAT et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review
- (2010) C. F. Deacon DIABETES OBESITY & METABOLISM
- Inhibition of multifunctional dipeptidyl peptidase-IV: Is there a risk of oncological and immunological adverse effects?
- (2010) Tomas Stulc et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Dipeptidyl peptidase 2 apoptosis assay determines the B-cell activation stage and predicts prognosis in chronic lymphocytic leukemia
- (2010) Alexey V. Danilov et al. EXPERIMENTAL HEMATOLOGY
- The dipeptidyl peptidase IV family in cancer and cell biology
- (2010) Denise M. T. Yu et al. FEBS Journal
- New aspects of melanocortin signaling: A role for PRCP in α-MSH degradation
- (2010) Sabrina Diano FRONTIERS IN NEUROENDOCRINOLOGY
- Dipeptidyl peptidase expression during experimental colitis in mice
- (2010) Roger Yazbeck et al. INFLAMMATORY BOWEL DISEASES
- Fibroblast activation protein expression in Crohnʼs disease strictures
- (2010) Laura Rovedatti et al. INFLAMMATORY BOWEL DISEASES
- Safety and efficacy of SITAgliptin plus GRanulocyte-colony-stimulating factor in patients suffering from Acute Myocardial Infarction (SITAGRAMI-Trial) — Rationale, design and first interim analysis
- (2010) Hans D. Theiss et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
- (2010) Jofre Tenorio-Laranga et al. Journal of Neuroinflammation
- Expanding the Dipeptidyl Peptidase 4-Regulated Peptidome via an Optimized Peptidomics Platform
- (2010) Arthur D. Tinoco et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Soluble CD26 / Dipeptidyl Peptidase IV Enhances Human Lymphocyte Proliferation In Vitro Independent of Dipeptidyl Peptidase Enzyme Activity and Adenosine Deaminase Binding
- (2010) D. M. T. Yu et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Biochemical properties and expression profile of human prolyl dipeptidase DPP9
- (2009) Hung-Kuan Tang et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Biochemistry, pharmacokinetics, and toxicology of a potent and selective DPP8/9 inhibitor
- (2009) Jia-Jing Wu et al. BIOCHEMICAL PHARMACOLOGY
- Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma
- (2009) Robert M Eager et al. BMC CANCER
- Recent insights into the role of dipeptidyl aminopeptidase IV (DPIV) and aminopeptidase N (APN) families in immune functions
- (2009) Siegfried Ansorge et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Role of dipeptidyl peptidase IV (DP IV)-like enzymes in T lymphocyte activation: investigations in DP IV/CD26-knockout mice
- (2009) Dirk Reinhold et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Phase II Trial of Talabostat and Docetaxel in Advanced Non-small Cell Lung Cancer
- (2009) R.M. Eager et al. CLINICAL ONCOLOGY
- The Cytoplasmic Peptidase DPP9 Is Rate-limiting for Degradation of Proline-containing Peptides
- (2009) Ruth Geiss-Friedlander et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Enzyme Activity and Immunohistochemical Localization of Dipeptidyl Peptidase 8 and 9 in Male Reproductive Tissues
- (2009) Véronique Dubois et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- The In Vivo Expression of Dipeptidyl Peptidases 8 and 9
- (2009) Denise M.T. Yu et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Neutrophils contain prolyl endopeptidase and generate the chemotactic peptide, PGP, from collagen
- (2009) Philip J. O'Reilly et al. JOURNAL OF NEUROIMMUNOLOGY
- Prolyl oligopeptidase binds to GAP-43 and functions without its peptidase activity
- (2009) Elena Di Daniel et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?
- (2009) Roger Yazbeck et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Distribution of dipeptidyl-peptidase IV on keratinocytes in the margin zone of a psoriatic lesion: a comparison with hyperproliferation and aberrant differentiation markers
- (2008) R. G. van Lingen et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Seprase: An overview of an important matrix serine protease
- (2008) Pamela O'Brien et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- CD26/dipeptidyl-peptidase IV in psoriatic skin: upregulation and topographical changes
- (2008) R.G. van Lingen et al. BRITISH JOURNAL OF DERMATOLOGY
- Reduced CD26bright expression of peripheral blood CD8+ T-cell subsets in psoriatic patients
- (2008) Rosanne G. van Lingen et al. EXPERIMENTAL DERMATOLOGY
- Stromal cell-derived factors 1α and 1β, inflammatory protein-10 and interferon-inducible T cell chemo-attractant are novel substrates of dipeptidyl peptidase 8
- (2008) Katerina Ajami et al. FEBS LETTERS
- Inhibiting dipeptidyl peptidase activity partially ameliorates colitis in mice
- (2008) Roger Yazbeck Frontiers in Bioscience-Landmark
- Non-substrate peptides influencing dipeptidyl peptidase IV/CD26 activity and immune cell function
- (2008) Sabine Wrenger Frontiers in Bioscience-Landmark
- Prolyl endopeptidase is revealed following SILAC analysis to be a novel mediator of human microglial and THP-1 cell neurotoxicity
- (2008) Andis Klegeris et al. GLIA
- Distribution of prolyl oligopeptidase in the mouse whole-body sections and peripheral tissues
- (2008) Timo T. Myöhänen et al. HISTOCHEMISTRY AND CELL BIOLOGY
- (R)-8-(3-Amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione (BI 1356), a Novel Xanthine-Based Dipeptidyl Peptidase 4 Inhibitor, Has a Superior Potency and Longer Duration of Action Compared with Other Dipeptidyl Peptidase-4 Inhibitors
- (2008) L. Thomas et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Expression and traffic of cellular prolyl oligopeptidase are regulated during cerebellar granule cell differentiation, maturation, and aging
- (2008) M.J. Moreno-Baylach et al. NEUROSCIENCE
- Prolyl oligopeptidase stimulates the aggregation of α-synuclein
- (2008) Inger Brandt et al. PEPTIDES
- The anti-inflammatory effect of neuropeptide Y (NPY) in rats is dependent on dipeptidyl peptidase 4 (DP4) activity and age
- (2008) Mirjana Dimitrijević et al. PEPTIDES
- Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function
- (2008) Kei Ohnuma et al. TRENDS IN IMMUNOLOGY
- The role of CD26/dipeptidyl peptidase IV in cancer
- (2007) Pamela et al. Frontiers in Bioscience-Landmark
- Protective effects of GLP-1 analogues exendin-4 and GLP-1(9–36) amide against ischemia–reperfusion injury in rat heart
- (2007) David P. Sonne et al. REGULATORY PEPTIDES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now